VÄSTRA FRÖLUNDA, Sweden--(BUSINESS WIRE)--Regulatory News: Artimplant (STO:ARTIB): Reported cases, by Dr. Jan Lidström, which involve 20 patients with soft tissue defects in the foot with up to four years follow-up together with a biomechanical study, by Dr. Eric Giza, confirm the positive clinical outcome orthopedic foot surgeons have experienced with Artelon® Tissue Reinforcement (ATR).
